20062019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Leila Russo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer

Mazzucchelli, S., Piccotti, F., Allevi, R., Truffi, M., Sorrentino, L., Russo, L., Agozzino, M., Signati, L., Bonizzi, A., Villani, L. & Corsi, F., Jun 15 2019, In : Biological Procedures Online. 21, 1, 12.

Research output: Contribution to journalArticle

Open Access
  • Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

    Viale, G., Hanlon Newell, A. E., Walker, E., Harlow, G., Bai, I., Russo, L., Dell’Orto, P. & Maisonneuve, P., Nov 1 2019, In : Breast Cancer Research and Treatment. 178, 2, p. 451-458 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

    Viale, G., de Snoo, F. A., Slaets, L., Bogaerts, J., van ’t Veer, L., Rutgers, E. J., Piccart-Gebhart, M. J., Stork-Sloots, L., Glas, A., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., Cardoso, F. & for the MINDACT investigators, Jan 1 2018, In : Breast Cancer Research and Treatment. 167, 1, p. 123-131 9 p.

    Research output: Contribution to journalArticle

  • Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies

    Hicks, D., Dell'Orto, P., Falzon, M., Hoff, K. D., Levy, Y. Y., McMahon, L., Miller, K., Russo, L. & Viale, G., 2017, In : Applied Immunohistochemistry and Molecular Morphology. 25, 5, p. 313-319 7 p.

    Research output: Contribution to journalArticle

  • Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance

    Viale, G., Slaets, L., de Snoo, F. A., Bogaerts, J., Russo, L., van’t Veer, L., Rutgers, E. J. T., Piccart-Gebhart, M. J., Stork-Sloots, L., Dell’Orto, P., Glas, A. M. & Cardoso, F., Feb 1 2016, In : Breast Cancer Research and Treatment. 155, 3, p. 463-469 7 p.

    Research output: Contribution to journalArticle